Viewing Study NCT06764095


Ignite Creation Date: 2025-12-24 @ 1:17 PM
Ignite Modification Date: 2025-12-29 @ 10:13 PM
Study NCT ID: NCT06764095
Status: RECRUITING
Last Update Posted: 2025-09-15
First Post: 2024-12-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial
Sponsor: Mayo Clinic
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module